Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  -  Page 130
Latest

Pacific Premier Bancorp’s net income climbs

By   /  Tuesday, January 24th, 2017  /  Banking & Finance, Banking Industry, Earnings, Latest news, Tri-County Public Companies  /  Comments Off on Pacific Premier Bancorp’s net income climbs

Pacific Premier Bancorp (PPBI), the holding company of Pacific Premier Bank, reported fourth quarter net income of $12 million, or 43 cents per diluted share, including $772,000 of merger-related expenses related to its pending acquisition of Heritage Oaks Bancorp. Net income was up from $8.1 million, or 37 cents per diluted share, in the fourth Read More →

Read More →
Latest

Salem Media Group acquires ChristianConcertAlerts.com

By   /  Thursday, January 19th, 2017  /  Latest news, Tri-County Public Companies  /  Comments Off on Salem Media Group acquires ChristianConcertAlerts.com

Camarillo-based Christian and conservative radio company Salem Media Group announced the acquisition of ChristianConcertAlerts.com. The website provides tour and event dates for more than 300 Christian musicians and 4,000 venues in the U.S. “I started ChristianConcertAlerts.com as a way to mobilize Christians across America in spreading the latest news about their favorite artists’ albums and tours and Read More →

Read More →
Latest

Community West Bank opens new Santa Maria Branch

By   /  Thursday, January 19th, 2017  /  Banking & Finance, Banking Industry, Latest news, Tri-County Public Companies  /  Comments Off on Community West Bank opens new Santa Maria Branch

Community West Bancshares, parent company of Community West Bank, announced the opening of its full-service Santa Maria branch at 122 Betteravia Road on Jan. 17, replacing its 2615 S. Miller St. location. The move continues its Central Coast expansion after the bank opened its first full-service San Luis Obispo branch at 4464 Broad St. in Read More →

Read More →
Latest

Patent ruling in favor of Amgen has shares skyrocketing

By   /  Friday, January 13th, 2017  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on Patent ruling in favor of Amgen has shares skyrocketing

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Limoneira reports strong revenue growth

By   /  Tuesday, January 10th, 2017  /  Agribusiness, Earnings, Latest news, Tri-County Public Companies  /  Comments Off on Limoneira reports strong revenue growth

Santa Paula agribusiness Limoneira reported increased revenues for the fourth quarter and fiscal year 2016, exceeding its guidance with an operating income of $9.2 million. Net income applicable to common stock, after preferred dividends, was $7.4 million for the year, or 52 cents per common share, up from $6.4 million in 2015. The company had announced expectations of operating Read More →

Read More →
Latest

Amgen updates agreement with DaVita for dialysis treatment

By   /  Monday, January 9th, 2017  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on Amgen updates agreement with DaVita for dialysis treatment

Thousand Oaks biotech company Amgen entered into a six-year supply agreement with DaVita for dialysis treatments, the company announced on Jan. 9. Under the terms of the new agreement, Amgen will supply DaVita with Epogen and Aranesp for agents to stimulate red blood cells in dialysis treatment in the United States and Puerto Rico. The Read More →

Read More →
Latest

Amgen partners with Immatics Biotechnologies to develop cancer drugs

By   /  Monday, January 9th, 2017  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on Amgen partners with Immatics Biotechnologies to develop cancer drugs

Thousand Oaks biotech company Amgen formed a potential $500 million partnership with Immatics Biotechnologies GmbH to research and develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancers, the company announced on Jan. 9. Under the terms of the agreement, Immatics will receive $30 million upfront and can receive more than $500 million in development, regulatory Read More →

Read More →